Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 4 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Weight Gain 1Neoplasms 1

Interventions

Metformin 7empagliflozin 2Tablets 2Letrozole 2Inositol 2Clomiphene 2thymoquinone 1semaglutide 1penclomedine 1chiglitazar 1Vaginal Creams, Foams, and Jellies 1Sitagliptin Phosphate 1Ovidrel 1Folic Acid 1Exenatide 1Curcumin 1Crinone 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Polycystic Ovary Syndrome × empagliflozin × Clear all
NCT06140108 2025-05-14

Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

SINA Health Education and Welfare Trust

Phase 2/3 Completed
70 enrolled

Polycystic Ovary Syndrome, Weight Gain

NCT03008551 2019-07-15

Empagliflozin vs Metformin in PCOS

Hull University Teaching Hospitals NHS Trust

Phase 2/3 Completed
40 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡